Dr. Damanpreet Singh Bedi, MD

Dr. Bedi practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Bedi's NPI, 1780721688, was assigned on January 31, 2007. Dr. Bedi graduated from University of Rochester Medical Center in 2004. Dr. Bedi holds Michigan license 4301103859.

Dr. Bedi's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Bedi's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Bedi is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Bedi to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bedi practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Bedi's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Bedi is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Bedi's licenses on file in 3 states: Michigan, California and Massachusetts.

Dmand AI lists kidney transplant among the conditions Dr. Bedi treats.

CMS data shows 55 Medicare services from Dr. Bedi across 4 procedure codes in 2024, for 72 Medicare patients. Medicare paid $26,099 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Bedi in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 22% are also on Medicaid. Their average risk score is 4.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bedi's median patient age at 59, with 54% women.

In 2024, Dr. Bedi wrote 58 Medicare Part D claims for 20 patients. 95% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $177 in total drug cost. In 2018, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bedi for performance year 2024, reported as part of a group. Dr. Bedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bedi as offering telehealth.

Dmand AI links 9 papers to Dr. Bedi, published from 2010 to 2023. The most frequent topics are Graft Rejection, Kidney Transplantation and Adoptive Transfer. Dr. Bedi has published most often in Transplantation. Dr. Bedi's most frequent co-authors are Dilip Samarapungavan, MD, Steven R. Cohn, MD and Irene K. Kim, MD.

CMS Open Payments shows 3 general payments to Dr. Bedi from 2 drug and device companies from 2019 to 2025. Travel and lodging make up the largest share, 96% of the total. TransMedics, Inc. paid the most, $2,572.

Dr. Bedi graduated from University of Rochester Medical Center in 2004.

Dr. Bedi is in network with 18 carriers, including Aetna, Health Alliance Plan and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.